Skip to content
Evigrade
CriticalPharmacokinetic enhancer (booster) for antiretroviral therapy×Antianginal – late sodium current inhibitor

Updated · Methodology

Mechanism

The liver and gut break down ranolazine mainly through the enzyme CYP3A4 and to a lesser extent through CYP2D6. Ranolazine is also a substrate of the transporter P-glycoprotein (P-gp), and inhibitors of CYP3A4 and P-gp raise its levels (ranolazine summary of product characteristics, SmPC, European Medicines Agency, EMA; ranolazine label, US Food and Drug Administration, FDA). Cobicistat boosts atazanavir or darunavir and is also part of combination tablets with these drugs or with elvitegravir (SmPCs of cobicistat and its combinations, EMA). Cobicistat is a strong CYP3A inhibitor, a weak CYP2D6 inhibitor and a P-gp inhibitor, and it raises the levels of drugs that CYP3A metabolises (cobicistat SmPC, EMA). The documents report no study of this pair. The strong CYP3A4 inhibitor ketoconazole 200 mg twice daily increased the area under the concentration-time curve (AUC) of ranolazine 3.0–3.9-fold (ranolazine SmPC, EMA). Higher ranolazine levels raise the risk of its dose-dependent adverse effects, such as nausea and dizziness, and prolong the corrected QT interval (QTc) further (ranolazine SmPC, EMA).

Symptoms

According to the US cobicistat label, combining it with ranolazine carries a risk of serious or life-threatening reactions (cobicistat label, US Food and Drug Administration, FDA). Dizziness, nausea and vomiting become more frequent as the ranolazine dose rises. In an intravenous overdose study in healthy volunteers, double vision, lethargy and fainting also occurred (ranolazine summary of product characteristics, SmPC, European Medicines Agency, EMA). Oral ranolazine overdose has caused low blood pressure, QT prolongation, slow heart rate, muscle jerks, severe tremor, unsteady gait and incoordination, dizziness, nausea, vomiting, speech difficulty and hallucinations. Extreme overdose has been fatal (ranolazine FDA label). QT prolongation itself causes no symptoms and shows only on an electrocardiogram. Ventricular arrhythmias cause palpitations, dizziness and fainting.

Management

The combination is contraindicated. People take cobicistat with atazanavir or darunavir. For both combinations, the US cobicistat label lists ranolazine among contraindicated drugs because of the risk of serious or life-threatening reactions (cobicistat label, US Food and Drug Administration, FDA). The EU summaries of product characteristics (SmPCs) of darunavir with cobicistat, including the combination tablets, also contraindicate ranolazine (SmPCs of darunavir and its cobicistat combinations, European Medicines Agency, EMA). The EU SmPCs of cobicistat itself and of its combinations with atazanavir or elvitegravir do not name ranolazine. However, the ranolazine SmPC contraindicates strong inhibitors of the enzyme CYP3A4, including human immunodeficiency virus (HIV) protease inhibitors. The cobicistat SmPC describes cobicistat as a strong CYP3A inhibitor (ranolazine and cobicistat SmPCs, EMA). Before and during cobicistat treatment, review all of the patient's medicines for interactions and monitor for their adverse reactions (cobicistat FDA label). Ranolazine is an add-on to beta-blockers or calcium antagonists when they are not enough or not tolerated (ranolazine SmPC, EMA). With cobicistat, use the beta-blockers metoprolol and timolol and the calcium antagonists amlodipine, diltiazem, felodipine, nicardipine, nifedipine and verapamil under clinical monitoring. These beta-blockers may need a lower dose (cobicistat SmPC, EMA). If ranolazine has nevertheless been taken with cobicistat and signs of ranolazine overdose appear, monitor the patient closely and give symptomatic and supportive treatment. Continuous electrocardiogram (ECG) monitoring may be needed. Haemodialysis is unlikely to clear ranolazine fully, because about 62% of it binds to plasma proteins (ranolazine SmPC, EMA, and FDA label).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Cobicistat

Other interactions with Ranolazine